Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.
Press releases published on June 3, 2025

NOVAGOLD and Paulson Advisers Complete $1 Billion Acquisition of Barrick Mining's 50% Interest in Donlin Gold
Paulson Advisers acquires a 40% ownership interest in Donlin Gold NOVAGOLD increases ownership interest in Donlin Gold from 50% to 60% Financial public offering and concurrent private placement raised sufficient funding for NOVAGOLD’s acquisition and for …

Ubigi, the Exclusive Officially Licensed eSIM Provider for EXPO 2025 Osaka, Kansai, Japan
Ubigi, the Exclusive Officially Licensed eSIM Provider for EXPO 2025 Osaka, Kansai, Japan, Pioneers the Future of Smart Tourism PARIS, FRANCE, June 3, 2025 /EINPresswire.com/ -- Ubigi, the travel eSIM brand of Transatel (an NTT company), proudly …

유비기, 일본 간사이 엑스포 2025 오사카의 독점 공식 라이선스 eSIM 제공업체로 스마트 관광의 미래를 선도하다
PARIS, FRANCE, June 3, 2025 /EINPresswire.com/ -- 파리- 일본 간사이에서 열리는 '엑스포 2025 오사카'의 공식 라이선스 독점 eSIM 공급업체로 선정된 것을 자랑스럽게 발표합니다. 2,800만 명 이상의 방문객이 예상되는, 10년 만에 최대 규모의 글로벌 행사인 ‘EXPO 2025 오사카·간사이’가 개최되는 가운데, Ubigi는 일본 전역에서 원활하고, 지속 가능하며, 즉각적인 연결을 제공함으로써 스마트 …

Barrick Completes Sale of 50% Interest in the Donlin Gold Project
All amounts expressed in U.S. dollars TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B) (TSX:ABX) announced today that it has completed the divestiture of its 50% interest in the Donlin Gold Project in Alaska to affiliates of …

Endeavour Silver Announces 2025 Annual General Meeting Voting Results and Retirement of Ricardo Campoy
VANCOUVER, British Columbia, June 03, 2025 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) is pleased to announce that shareholders voted in favour of all items of business at the Company’s 2025 Annual …

Cyviz to Highlight Channel-First Strategy and Advanced AV Solutions at InfoComm 2025
ORLANDO, FL, UNITED KINGDOM, June 3, 2025 /EINPresswire.com/ -- Cyviz, a global leader in advanced visualization and collaboration solutions, is pleased to announce its participation in InfoComm 2025, the premier event for AV professionals, taking place …

Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer
TEL AVIV, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today the pricing and early acceptance results of its previously announced tender offers (the “Offers”) to purchase for cash …

WinnerMining launches new energy power project.
Boston, Massachusetts, June 03, 2025 (GLOBE NEWSWIRE) -- With the changes of the times and the advancement of technology, people's attitudes towards energy have also changed. People also understand how cloud mining works. However, traditional cloud mining …

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program
Recently disclosed clinical cohort data from high (1x1015 total vg) and low dose (5.7x1014 total vg) TSHA-102 from REVEAL adolescent/adult and pediatric Phase 1/2 trials Caregiver research regarding gain/regain of developmental milestones supporting …

Cable TV Pioneers Welcome New Class of 2025
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- The Cable TV Pioneers will induct 33 new members in its Class of 2025 at its 59th Annual Banquet in Washington, D.C., Sunday, September 28, 2025. This year’s class includes a variety of leaders and achievers from …

Aecon announces voting results of Annual General Meeting
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Aecon Group Inc. (TSX: ARE) (“Aecon” or the “Corporation”) announced today that the nominees listed in the Management Information Circular dated May 5, 2025, were elected as directors of Aecon, to hold office …

Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today …

Softil and Mocotec Team Up to Bring Germany's Public Safety Agencies into the World of Mission-Critical Communications
Mocotec using Softil's BEEHD MCX technology to develop advanced measuring and analysis tools for 3GPP compliant MCX terminal devices, services and equipment TEL AVIV, ISRAEL, June 3, 2025 /EINPresswire.com/ -- Softil, the world’s leading mission- …

Fennec Announces Results of Annual Meeting
RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 25, 2025 were elected as directors of …

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to two new employees. Effective June 1, 2025, in connection with commencing employment, two …

DBV Technologies publie un amendement à son Document d’enregistrement universel 2024
Châtillon, France, le 3 juin 2025 DBV Technologies publie un amendement à son Document d’enregistrement universel 2024 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), (la « Société »), société biopharmaceutique en …

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company …

Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa
ORION OYJ LEHDISTÖTIEDOTE 3.6.2025 klo 23.30 Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa Darolutamidi on ensimmäinen ja ainoa androgeenireseptorin …

Outset Medical Appoints Renee Gaeta as Chief Financial Officer
SAN JOSE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of Renee …

U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer Darolutamide is the first and only in the U.S. and FDA-approved androgen receptor inhibitor ( …